Home
About
Capbilities
R&D
Investors
News
Careers
中文
Home
About
Capbilities
R & D
Investors
News
Careers
Press Release
Press Release
2022
2021
2020
2019
2018
2017
Jun 17, 2022
The IND Application for 6MW3511 Injection - An Innovative Drug from Mabwell is Accepted by NMPA
?
Mar 28, 2022
Achievements in Scientific Research | Mabwell Published ADE Mechanism of SARS-CoV-2 Neutralizing Antibodies in Communications Biology
?
Mar 08, 2022
Facilitate Development and Accelerate Progress | Zhangjiang Town Leaders Visit Mabwell Bioscience to Research and Guide Work
?
Mar 03, 2022
Good News! Mabwell's First Drug Adalimumab Approved for Marketing
?
Feb 17, 2022
The IND Application of Mabwell Innovative Drug 8MW2311 for Injection was Accepted by NMPA
?
Feb 14, 2022
Through New Chapter | Industry Big Names Discuss the Rheumatism Immunity Disease Webinar
?
Feb 11, 2022
Facilitate Development and Accelerate Progress│SHEITC Visit Mabwell to Research and Guide Work
?
Jan 18, 2022
Good News | Mabwell is Officially Listed on the Shanghai Stock Exchange STAR Market
?